Evidence map›Paper›PMID 31801907›Full record

ArticleJCI insight2019

FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.

Zhousheng Xiao, Gwendalyn King, Salvatore Mancarella, Undral Munkhsaikhan, Li Cao, Chun Cai, Leigh Darryl Quarles

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Structural asymmetry in FGF23 signaling.Trends in pharmacological sciences · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zhousheng XiaoDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Gwendalyn KingDepartment of Biology, Creighton University, Omaha, Nebraska, USA.
Salvatore MancarellaDepartment of Physiology and.
Undral MunkhsaikhanDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Li CaoDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Chun CaiDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Leigh Darryl QuarlesDepartment of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
University of Tennessee Health Science Center · USCreighton University · US

Funding

Regulation and Function of FGF23R01AR045955 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI QUARLES, L DARRYL · 1999 to 2016
$4.8M
Skeletal Functions of Polycystins and TAZR01AR071930 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI XIAO, ZHOUSHENG · 2018 to 2022
$1.6M
Optimization of Novel Small Molecules to Antagonize FGF-23R01DK121132 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI XIAO, ZHOUSHENG · 2019 to 2023
$1.5M
NIAMS NIH HHS R01 AR045955NIAMS NIH HHS R01 AR071930NIDDK NIH HHS R01 DK121132
6 · The paper itself

Abstract

Observations in transgenic α-Klotho (Kl) mice (KlTg) defined the antiaging role of soluble Klotho (sKL130). A genetic translocation that elevates sKL levels in humans is paradoxically associated with increased circulating fibroblast growth factor 23 (FGF23) levels and the potential of both membrane KL (mKL135) and sKL130 to act as coreceptors for FGF23 activation of fibroblast growth factor receptors (FGFRs). Neither FGF23 expression nor the contributions of FGF23, mKL135, and sKL130 codependent and independent functions have been investigated in KlTg mice. In the current study, we examined the effects of Kl overexpression on FGF23 levels and functions in KlTg mice. We found that mKL135 but not sKL130 stimulated FGF23 expression in osteoblasts, leading to elevated Fgf23 bone expression and circulating levels in KlTg mice. Elevated FGF23 suppressed 1,25(OH)2D and parathyroid hormone levels but did not cause hypophosphatemic rickets in KlTg mice. KlTg mice developed low aldosterone-associated hypertension but not left ventricular hypertrophy. Mechanistically, we found that mKL135 and sKL130 are essential cofactors for FGF23-mediated ERK activation but that they inhibited FGF23 stimulation of PLC-γ and PI3K/AKT signaling. Thus, increased longevity in KlTg mice occurs in the presence of excess FGF23 that interacts with mKL and sKL to bias FGFR pathways.

Indexed as

AldosteroneAnimalsBone and BonesCardiovascular DiseasesDisease Models, AnimalFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsGene Knockout TechniquesGlucuronidaseKidneyKlotho ProteinsLongevityMaleMiceMice, Inbred C57BLAldosteroneFGF23 protein, humanFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsGlucuronidaseKlotho ProteinsProtein IsoformsBone BiologyCardiovascular disease

Identifiers

PMID31801907
PMCPMC6962016
OpenAlexW2994604017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.